Increase in Key KPIs
First written in FY2023. 2 of 9 entries say "Cited as achieved", first in 2026-03-04. Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1Added interim consolidated resultsAnnual report
「As a result, during the interim consolidated accounting period, the Group recorded revenue of ¥580,567 thousand (up 10.2% year on year), an operating loss of ¥26,289 thousand (an operating loss of ¥42,381 thousand in the same period of the previous year), an ordinary loss of ¥25,417 thousand (an ordinary loss of ¥41,580 thousand in the same period of the previous year) and an interim net loss attributable to owners of the parent of ¥16,666 thousand (an interim net loss attributable to owners of the parent of ¥29,713 thousand in the same period of the previous year).」
Interim consolidated results for the first half of 2026 were added. Revenue increased 10.2% year on year, while the operating loss, ordinary loss and interim net loss attributable to owners of the parent all narrowed, although the operating loss continued. - 2026-05-15Cited as achievedFinancial results presentation
「Revenue increased 3.6% year on year to ¥291 million.」
The company reported net sales of ¥291 million for the first quarter of the fiscal year ending December 2026, an increase year on year. - FY2025Added annual resultsAnnual report
「Key indicators Fiscal year ended December 2024 Fiscal year ended December 2025 Change rate/change Revenue (¥ thousand) 1,333,059 1,078,086 - Operating profit or operating loss (¥ thousand) 157,517 △33,937 - Reservation transaction value (¥ thousand) 12,147,180 11,806,412 △2.8% MRSO.jp listed medical facilities (facilities) 1,677 1,906 229」
Annual results for the fiscal year ended December 2025 were added. Revenue declined and the company moved into an operating loss, while reservation transaction value decreased 2.8% and listed medical facilities increased by 229. - 2026-03-04Cited as achievedGeneral Meetings of Shareholders
「As a result, for the consolidated fiscal year, net sales were ¥1,078,086 thousand, operating loss was ¥33,937 thousand, ordinary loss was ¥33,437 thousand, and net loss attributable to owners of the parent was ¥23,005 thousand.」
The company reported lower net sales and an operating loss, ordinary loss and net loss attributable to owners of the parent for the fiscal year ended December 2025. - FY2025-H1Added interim consolidated resultsAnnual report
「As a result, during the interim consolidated accounting period, the Group recorded revenue of ¥527,020 thousand, an operating loss of ¥42,381 thousand, an ordinary loss of ¥41,580 thousand and an interim net loss attributable to owners of the parent of ¥29,713 thousand.」
In the first half of 2025, revenue was ¥527,020 thousand, the operating loss was ¥42,381 thousand, the ordinary loss was ¥41,580 thousand and the interim net loss attributable to owners of the parent was ¥29,713 thousand. Compared with the standalone results for the same period of the previous year, revenue declined and the company moved into the red. - FY2024Added annual resultsAnnual report
「Reservation transaction value (¥ thousand) 10,932,914 12,147,180 11.1%; MRSO.jp listed medical facilities (facilities) 1,366 1,677 311; contracted accounts (accounts) 877 280 △597」
Key results for the fiscal year ended December 2024 were added. Reservation transaction value and listed medical facilities increased, while contracted accounts declined due to the end of vaccination-related services and revenue and operating profit also decreased. - FY2024-H1Added interim resultsAnnual report
「As a result, during the interim accounting period, the company recorded revenue of ¥682,844 thousand, operating profit of ¥97,288 thousand, ordinary profit of ¥97,164 thousand and interim net profit of ¥67,088 thousand.」
Revenue was ¥682,844 thousand, operating profit ¥97,288 thousand, ordinary profit ¥97,164 thousand and interim net profit ¥67,088 thousand during the interim accounting period. Service revenue was HCPF ¥356,970 thousand, DX ¥325,233 thousand and large-scale vaccination and other services ¥640 thousand. - FY2024-Q1First-Quarter Results AddedAnnual report
「As a result, during the cumulative first-quarter period, the company recorded revenue of ¥430,865 thousand, operating profit of ¥125,270 thousand, ordinary profit of ¥125,268 thousand and quarterly net profit of ¥86,713 thousand.」
Revenue was ¥430,865 thousand, operating profit ¥125,270 thousand, ordinary profit ¥125,268 thousand and quarterly net profit ¥86,713 thousand during the cumulative first-quarter period. By service, HCPF revenue was ¥184,652 thousand, DX service revenue ¥245,733 thousand and large-scale vaccination and other service revenue ¥480 thousand. - FY2023First statedAnnual report
「Reservation transaction value (¥ thousand) 9,924,914 10,932,914 +10.2%; MRSO.jp listed medical facilities (facilities) 1,326 1,366 +40; contracted accounts (accounts) 765 877 +112」
For the fiscal year ended December 2023, reservation transaction value, listed medical facilities and contracted accounts all increased from the previous fiscal year.